Table 2.
CTR− | CTR+ | CUR1 | CTRAl | CUR2 | |
---|---|---|---|---|---|
MDA | 0.62 ± 0.26 | 0.95 ± 0.05 a | 0.51 ± 0.20 b | 1.05 ± 0.09 | 0.60 ± 0.02 b,* |
CAT | 0.76 ± 0.54 | 0.19 ± 0.03 a | 0.83 ± 0.26 b | 0.10 ± 0.09 | 0.89 ± 0.01 b,* |
SOD | 0.10 ± 0.06 | 0.05 ± 0.01 a | 0.11 ± 0.081 b | 0.05 ± 0.01 | 0.15 ± 0.09 b,* |
Values are mean ± SEM. Note: CTR−: negative control group; CTR+: positive control group (treated by aluminum chloride (AlCl3)); CUR1: co-treatment with curcumin; CUR2: post-treatment with curcumin; CTRAl: exposed to AlCl3 for 90 days and survive 60 days without any treatment; a: p < 0.05 as compared to CTR− group; b: p < 0.05 as compared to CTR+ group; *: p < 0.05 as compared to CTRAl group, repeated measures two-way ANOVA followed by Tukey’s test for multiple comparisons.